Larotrectinib

Trade Name: 
Vitrakvi
Manufacturer/Distributor: 
Bayer Inc.
Classification: 
Antineoplastic agent
ATC Class: 
L01EX12 - larotrectinib
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2019/07/04
Date Marketed in Canada (yyyy/mm/dd): 
2019/07/10
Presentation: 
Capsule: 25 mg. DIN: 02490315
Capsule: 100 mg. DIN: 024190323
Oral solution: 20 mg/mL. DIN: 02490331
Comments: 
NOC/c - for treatment of adults and children with solid tumors (see product monograph for specifics).